Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOST | Q9BQB4 | 1/20 | 0.61 |
| ▸ | TYMS | P04818 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | DHFR | P00374 | 3/20 | 0.59 |
| ▸ | MTHFD1 | P11586 | 3/20 | 0.57 |
| ▸ | MTHFD2 | P13995 | 2/20 | 0.56 |
| ▸ | GART | P22102 | 4/20 | 0.55 |
| ▸ | ATIC | P31939 | 3/20 | 0.55 |
| ▸ | FPGS | Q05932 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrofolic Acid SCHEMBL8281 | 1.00 | SOST (0.61) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL12136386 | 1.00 | SOST (0.61) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL27589172 | 1.00 | SOST (0.61) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL27415499 | 0.99 | SOST (0.60) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL27779274 | 0.98 | SOST (0.60) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL5159976 | 0.95 | SOST (0.59) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL29510656 | 0.95 | TYMS (0.56) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL28902275 | 0.95 | SOST (0.56) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL28796610 | 0.95 | SOST (0.56) | SOSTTYMSKDM4EMEN1ALDH1A1 | |
| Dihydrofolic Acid SCHEMBL31299576 | 0.93 | SOST (0.53) | SOSTTYMSKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3495487-B1 | PROMOTER WITH A REGION RICH IN CYTOSINE-GUANINE DINUCLEOTIDES, VECTORS, CELLULAR LINES, METHOD FOR PRODUCING RECOMBINANT PROTEIN | UNIV CHILE (CL) | 2026-04-29 | — | — | EP | claimed |
| EP-4282978-B1 | A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER | GAVISH GALILEE BIO APPL LTD (IL) | 2026-04-01 | — | — | EP | claimed |
| EP-3678682-B1 | METHODS, COMPOSITIONS AND CELLS FOR PREPARING SURFACTANT PROTEIN D (SP-D) | AIRWAY THERAPEUTICS INC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4182467-B1 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS FOR MULTIPARTITE GENE DELIVERY | ABEONA THERAPEUTICS INC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-3551657-B1 | CHIMERIC CHLOROTOXIN RECEPTORS | UAB RES FOUND (US) | 2026-02-04 | — | — | EP | claimed |
| US-20260028717-A1 | METHOD FOR PREPARING METALLIC COBALT THIN FILM AND METHOD FOR PREPARING COBALT SILICIDE THIN FILM | INST OF MICROELECTRONICS CAS (CN) | 2026-01-29 | — | — | US | claimed |
| EP-4676472-A2 | BI-SPECIFIC ADAPTERS AND THEIR USE WITH UNIVERSAL CAR-T CELLS IN THE TREATMENT OF TUMORS AND THE INHIBITION OF CANCER-ASSOCIATED FIBROBLASTS | Purdue Research Foundation (US) | 2026-01-14 | — | — | EP | claimed |
| EP-3953480-B1 | TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS | DNA TWOPOINTO INC (US) | 2025-12-03 | — | — | EP | claimed |
| EP-3625238-B1 | NOVEL SPIRO-LACTAM COMPOUNDS, PROCESS AND USES THEREOF | UNIV DE COIMBRA (PT) | 2025-11-26 | — | — | EP | claimed |
| US-20110244575-A1 | METHODS, SYSTEMS AND COMPOSITIONS FOR INCREASED MICROORGANISM TOLERANCE TO AND PRODUCTION OF 3-HYDROXYPROPIONIC ACID (3-HP) | OPX BIOTECHNOLOGIES, INC. | 2011-10-06 | — | — | US | claimed |
| US-20100210017-A1 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2010-08-19 | — | — | US | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| EP-2126042-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | The Regents of the University of Colorado (US) | 2009-12-02 | — | — | EP | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| WO-2008089102-A2 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2008-07-24 | — | — | WO | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| US-5872104-A | BACTERICIDES AND RESISTANT BACTERIA WITH METHYLATION INHIBITORS | ORIDIGM CORPORATION (US) | 1999-02-16 | — | — | US | claimed |
| WO-1996020010-A1 | COMBINATION FOR REDUCING ANTIMICROBIAL RESISTANCE USING A METHYLATION INHIBITOR IN COMBINATION WITH AN ANTIBIOTIC | ORIDIGM CORPORATION (US) | 1996-07-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028717-A1 | METHOD FOR PREPARING METALLIC COBALT THIN FILM AND METHOD FOR PREPARING COBALT SILICIDE THIN FILM | CDH1, DCAF1, ADH1C | SOST 748/4885TYMS 3801/4885KDM4E 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.